Sandoz Group AG (SWX:SDZ)
Switzerland · Delayed Price · Currency is CHF 83.86
+0.48 (0.58%)
Nov 11, 2026, 12:52 PM CET
Sandoz Group AG Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,676 | 11,157 | 10,384 | 9,979 | 9,306 | 9,678 |
Revenue Growth | 4.65% | 7.44% | 4.06% | 7.23% | -3.84% | 0.21% |
Gross Profit Gross Profit Growth | 5,580 | 5,300 | 4,934 | 4,564 | 4,378 | 4,599 |
Operating Income Operating Income Growth | 1,082 | 1,445 | 293 | 375 | 1,239 | 1,394 |
Net Income Net Income Growth | 646 | 914 | - | 77 | 848 | 908 |
Earnings Per Share EPS Growth | 1.47 | 2.09 | - | 0.18 | 1.97 | - |
EPS Growth | -29.73% | - | - | -90.91% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biosimilars Biosimilars Growth | 3,807 | 3,292 | 2,853 | 2,215 | 1,928 | 1,945 |
Generics Generics Growth | 7,925 | 7,794 | 7,504 | 7,432 | 7,141 | 7,498 |
Other Other Growth | - | 71 | 27 | 332 | 237 | 235 |
Revenue (Total) Revenue (Total) Growth | - | 11,157 | 10,384 | 9,979 | 9,306 | 9,678 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,270 | 1,739 | 1,191 | 1,109 | 74 | 40 |
Total Debt Total Debt Growth | 6,203 | 5,699 | 4,869 | 4,568 | 4,185 | 4,941 |
Net Cash (Debt) Net Cash Growth | -3,933 | -3,960 | -3,678 | -3,459 | -4,111 | -4,901 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.98 | -9.07 | -8.47 | -8.02 | -9.56 | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,942 | 1,594 | 656 | 362 | 1,223 | 1,354 |
Capital Expenditures CapEx Growth | -556 | -493 | -404 | -364 | -278 | -313 |
Free Cash Flow Free Cash Flow Growth | 1,386 | 1,101 | 252 | -2 | 945 | 1,041 |
Free Cash Flow Growth | 25.89% | 336.91% | - | - | -9.22% | 19.38% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.79% | 47.50% | 47.52% | 45.74% | 47.04% | 47.52% |
Operating Margin | 9.27% | 12.95% | 2.82% | 3.76% | 13.31% | 14.40% |
Pretax Margin | 7.20% | 10.82% | -0.11% | 1.30% | 11.84% | 13.57% |
Profit Margin | 5.53% | 8.19% | - | 0.77% | 9.11% | 9.38% |
FCF Margin | 11.87% | 9.87% | 2.43% | -0.02% | 10.15% | 10.76% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 1.009 | 0.662 | 0.534 |
Dividend Per Share Growth | 33.33% | 52.37% | 23.90% | - |
Dividend Yield | 0.95% | 1.39% | 1.61% | 1.66% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 70.67 | 34.37 | - | 179.88 | - | - |
Forward PE | 22.82 | 19.12 | 12.88 | 12.21 | - | - |
P/FCF Ratio | 32.33 | 28.54 | 70.11 | - | - | - |
PS Ratio | 3.84 | 2.82 | 1.70 | 1.39 | - | - |